Vera Therapeutics Inc
General ticker "VERA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6B
Vera Therapeutics Inc follows the US Stock Market performance with the rate: 44.9%.
Estimated limits based on current volatility of 3.1%: low 40.77$, high 43.34$
Factors to consider:
- Current price 104.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [9.40$, 20.68$]
- 2024-12-30 to 2025-12-30 estimated range: [7.74$, 17.72$]
Financial Metrics affecting the VERA estimates:
- Negative: Non-GAAP EPS, $ of -2.29 <= 0.10
- Negative: Operating profit margin, % of -98.21 <= 1.03
- Negative: Operating cash flow per share per price, % of -13.05 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.92
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term VERA quotes
Long-term VERA plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $1.86MM |
Operating Expenses | $34.40MM | $90.90MM | $103.87MM |
Operating Income | $-34.40MM | $-90.90MM | $-102.01MM |
Non-Operating Income | $1.79MM | $1.85MM | $6.02MM |
Interest Expense | $0.02MM | $0.99MM | $0.00MM |
R&D Expense | $22.48MM | $68.99MM | $78.22MM |
Income(Loss) | $-32.61MM | $-89.06MM | $-95.99MM |
Taxes | $0.00MM | $0.00MM | $0.00MM |
Profit(Loss) | $-32.61MM | $-89.06MM | $-95.99MM |
Stockholders Equity | $69.59MM | $76.91MM | $101.69MM |
Assets | $83.75MM | $131.44MM | $175.55MM |
Operating Cash Flow | $-23.71MM | $-67.60MM | $-92.18MM |
Capital expenditure | $0.00MM | $0.06MM | $0.06MM |
Investing Cash Flow | $-4.20MM | $-70.55MM | $-39.43MM |
Financing Cash Flow | $53.88MM | $101.93MM | $133.54MM |
Earnings Per Share* | $-1.53 | $-3.35 | $-2.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.